thyssenkrupp nucera AG & Co. KGaA/€NCH2

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About thyssenkrupp nucera AG & Co. KGaA

thyssenkrupp nucera AG & Co. KGaA specializes in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies, focusing on green hydrogen, chlor-alkali, and hydrochloric acid solutions. Serving industries such as chemical manufacturing, steel production, and refineries, the company has completed over 600 electrolysis projects worldwide, totaling more than 10 gigawatts of installed capacity. Founded in 1960 and headquartered in Dortmund, Germany, thyssenkrupp nucera operates globally with locations in the United States, Italy, Saudi Arabia, Australia, China, and Japan. The company's strategic positioning is bolstered by its extensive experience in electrochemical plant construction and its commitment to advancing green hydrogen production technologies.

Ticker

€NCH2

Primary listing

XETRA

Industry

Construction and Engineering
Headquarters

Employees

1,083

NCH2 Metrics

BasicAdvanced
€1.3B
54.13
€0.19
-
-

Bulls say / Bears say

Thyssenkrupp Nucera reported a 27% increase in sales to EUR 262 million in Q1 2024/2025, marking the highest quarterly sales in its history, driven by advancements in the green hydrogen and chlor-alkali sectors. (webdisclosure.com)
The company secured a significant contract to expand a chlor-alkali plant in Jubail, Saudi Arabia, valued at approximately EUR 15 million, indicating strong international demand for its technologies. (ad-hoc-news.de)
Thyssenkrupp Nucera's inclusion in the SDAX index reflects its growing market capitalization and investor confidence, potentially attracting more institutional investment. (eqs-news.com)
Despite strong sales growth, the company anticipates EBIT between minus EUR 30 million and plus EUR 5 million for fiscal year 2025, indicating potential profitability challenges. (marketscreener.com)
Order intake in the green hydrogen segment decreased to EUR 5 million in Q1 2024/2025 from EUR 109 million in the same period the previous year, highlighting market volatility and project delays. (webdisclosure.com)
The company faces ongoing regulatory uncertainties and slow approval processes in the hydrogen industry, which could impede project execution and revenue realization. (eqs-news.com)
Data summarised monthly by Lightyear AI. Last updated on 30 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €NCH2

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs